Health Trials

Symptomatic Tricuspid Regurgitation

2

Review clinical trials related to Symptomatic Tricuspid Regurgitation. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)

Pivotal trial to evaluate the safety and clinical efficacy of the VDyne System for the treatment of symptomatic severe or greater tricuspid regurgitation.

Participants needed: 730
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: VDyne, Inc.Updated: Aug 17, 2026Locations: 1
Eligibility criteria

Age ≥18 years old [+7]

Subject unable or unwilling to comply with study required testing and follow-up... [+17]

Read more
Status: Not yet recruiting

Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System

The objective of this clinical study is to assess the safety and efficacy of the Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System for the treatment of symptomatic subjects with at least severe tricuspid regurgitation (TR).

Participants needed: 700
Trial details
Age: 18-90Biological sex: AllType: InterventionalSponsor: Laplace Interventional, IncUpdated: Jul 22, 2026
Eligibility criteria

18 - 90 years of age at the time of the study procedure. [+5]

Estimated life expectancy of less than 12 months. [+8]

Read more